Botanix Issues New Shares, Enhances Dermatology Offerings
Company Announcements

Botanix Issues New Shares, Enhances Dermatology Offerings

Botanix Pharmaceuticals Limited (AU:BOT) has released an update.

Botanix Pharmaceuticals Limited has issued 4 million new shares following the exercise of options and has complied with regulatory requirements, enabling immediate trading of these shares. The company specializes in dermatology, with their flagship product Sofdra™, an FDA-approved treatment for axillary hyperhidrosis, marking a significant advancement for patients with this medical condition.

For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App